Published October 3, 2024 | Version 4
Journal Open

Highlighting the Importance of Newborn Screening in India by Comparative Analysis of IEMs in High-Risk Babies with Methylmalonic Acidemia (MMA)

  • 1. 1MILS International India, Navigene Genetic Science Lab, Mumbai & Shri JJT University, Jhunjhunu Rajasthan – 333010 2 Shri JJT University, Jhunjhunu Rajasthan – 333010

Description

This  is  a  comparative  analysis  of 
7789  high-risk  IEM  cases,  using  the  example 
of   methylmalonic   acidemia   (MMA),   a   rare 
metabolic  disorder  to  emphasize  the  critical 
role  of  newborn  screening  in  early  diagnosis 
and management. Case 1 involves a patient not 
diagnosed  at  birth  through  newborn  screening, 
while Case 2 involves a patient diagnosed in the 
neonatal period due to symptom presentation. The 
differences in their clinical outcomes underline the 
importance  of  early  detection  through  newborn 
screening  programs.  The  MMA  was  the  most 
common  organic  aciduria  with  an  incidence  of 
1:26 diagnosed among 12 common IEMs causing 
developmental  delay,  disabilities,  or  death  in 
high-risk  neonates  &  children.  These  12  IEMs 
(incidence 1: 26 to 409) with high incidence are 
strongly recommended as candidate disorders for 
newborn screening programs in India. This paper 
compares  two  cases  of  MMA  to  illustrate  the 
significant impact of newborn screening.

Files

CASE REPORT-5 (REVISED).pdf

Files (277.3 kB)

Name Size Download all
md5:8c53b7193b724ec7b8d9f94332b2383b
277.3 kB Preview Download

Additional details

Dates

Accepted
2024-09-26

References

  • 1. Hörster F, Garbade SF, Zwickler T, Aydin HI, Bodamer OA, Burlina AB, Das AM, De Klerk JBC, Dionisi-Vici C, Geb S, Gökcay G, Guffon N, Maier EM, Morava E, Walter JH, Schwahn B, Wijburg FA, Lindner M, Grünewald S, Baumgartner MR, Kölker S. Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters. J Inherit Metab Dis. 2009;32(5):630. 2. Qiliang L, Wenqi S, Quan W, Xinying Y, Jiuwei L, Qiang S, Xiaoxia P, Peichang W. Predictors of survival in children with methylmalonic acidemia with homocystinuria in Beijing, China: a prospective cohort study. Indian Pediatr. 2015;52(2):119-124. 3. Riphagen IJ, Minović I, Groothof D, Post A, Eggersdorfer ML, Kootstra-Ros JE, de Borst MH, Navis G, Muskiet FAJ, Kema IP, Heiner-Fokkema MR, Bakker SJL. Methylmalonic acid, vitamin B12, renal function, and risk of all-cause mortality in the general population: results from the prospective Lifelines-MINUTHE study. BMC Med. 2020;18(1):380. 4. Barahate S, Chandel A, Kolhe S, Chauhan V, Jain M. Early neonatal presentation of methylmalonic aciduria: a case report from rural central India. Int J ContempPediatr. 2023;10:587-589. 5. Dave U. Genetic Counseling Approach in Inborn Errors of Metabolism. In: Genetic Counseling: Clinical and Laboratory Approach. Editors : Usha Dave & Dhanalaxmi Shetty Jaypee Brothers Medical Publishers; 2021. Chapter 17, p. 219-233. 6. Matsumoto I, Kuhara T. A new chemical diagnostic method for inborn errors of metabolism by mass spectrometry—rapid, practical, and simultaneous urinary metabolites analysis. MassSpectrom Rev. 1996;15(1):43-57.